Woodline Partners »

Immunic shares owned by Woodline Partners

Quarter-by-quarter ownership of Immunic (IMUX) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Immunic

Tip: Access up to 7 years of quarterly data

All positions including Immunic held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunic by Woodline Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $7.2M 472k 15.37

More positions owned by Woodline Partners

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Revolution Medicines (RVMD)
Alphabet Cap Stk Cl C (GOOG)
Micron Technology (MU)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Johnson & Johnson (JNJ)
Verizon Communications (VZ)
Microchip Technology (MCHP)

View all positions for Woodline Partners

Top funds holding Immunic

Standard Life Aberdeen
BVF
Millennium Management
Avidity Partners Management
Braidwell
Laurion Capital Management
Vanguard Capital Management
Woodline Partners
Soleus Capital Management
Propel Bio Management
Susquehanna International
Nantahala Capital Management
UBS Group
Geode Capital Management
683 Capital Management

View all funds holding Immunic